We are live on ! Find out more
First Quadrant

First Quadrant Portfolio holdings

AUM $18M Turnover 89.22%
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.72B
AUM Growth
+$190M
Cap. Flow
+$63.1M
Cap. Flow %
1.34%
Top 10 Hldgs %
13.44%
Holding
963
New
145
Increased
195
Reduced
238
Closed
94
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.4 years

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$40.3M
2
VZ icon
Verizon
VZ
+$38.9M
3
SLB icon
SLB
SLB
+$33.9M
4
JNJ icon
Johnson & Johnson
JNJ
+$30.3M
5
INTU icon
Intuit
INTU
+$25.9M

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Healthcare 14.37%
3 Financials 13.33%
4 Consumer Discretionary 11.76%
5 Industrials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CI icon
176
Cigna
CI
$77.5B
$9.03M 0.19%
69,300
-20,400
-23% -$2.66M
2013 Q2
13 quarters
CCK icon
177
Crown Holdings
CCK
$13B
$8.9M 0.19%
155,858
+137,458
+747% +$7.37M
2013 Q2
13 quarters
WBD icon
178
DELISTED
Warner Bros
WBD
$8.88M 0.19%
329,827
+294,027
+821% +$7.54M
2013 Q2
13 quarters
CBSH icon
179
Commerce Bancshares
CBSH
$7.72B
$8.77M 0.19%
290,018
+289,235
+36,939% +$8.63M
2013 Q2
13 quarters
MO icon
180
Altria Group
MO
$129B
$8.68M 0.18%
137,354
-233,544
-63% -$15.5M
2014 Q4
7 quarters
INGR icon
181
Ingredion
INGR
$5.68B
$8.65M 0.18%
65,007
+47,068
+262% +$6.29M
2013 Q2
13 quarters
SBH icon
182
Sally Beauty Holdings
SBH
$1.67B
$8.61M 0.18%
335,247
-202,653
-38% -$5.68M
2013 Q2
13 quarters
CELG
183
DELISTED
Celgene
CELG
$8.44M 0.18%
80,739
+139
+0.2% +$15K
2013 Q2
13 quarters
DDS icon
184
Dillards
DDS
$8.7B
$8.35M 0.18%
132,528
+82,343
+164% +$5.15M
2013 Q2
13 quarters
CHE icon
185
Chemed
CHE
$7.09B
$8.26M 0.17%
58,521
+30,021
+105% +$4.18M
2013 Q2
13 quarters
RGA icon
186
Reinsurance Group of America
RGA
$17.5B
$7.91M 0.17%
73,261
– –
2013 Q2
13 quarters
EW icon
187
Edwards Lifesciences
EW
$60.6B
$7.63M 0.16%
189,900
– –
2013 Q2
13 quarters
NXPI icon
188
NXP Semiconductors
NXPI
$63.7B
$7.6M 0.16%
74,496
-111
-0.1% -$9.41K
2015 Q4
3 quarters
CPRT icon
189
Copart
CPRT
$29.1B
$7.59M 0.16%
1,133,696
+919,296
+429% +$5.86M
2013 Q2
13 quarters
C icon
190
Citigroup
C
$198B
$7.57M 0.16%
160,353
-10,145
-6% -$461K
2013 Q2
13 quarters
JAZZ icon
191
Jazz Pharmaceuticals
JAZZ
$15.4B
$7.54M 0.16%
62,038
-6,385
-9% -$861K
2013 Q2
13 quarters
LLL
192
DELISTED
L3 Technologies
LLL
$7.54M 0.16%
50,000
– –
2016 Q1
2 quarters
BR icon
193
Broadridge
BR
$21.3B
$7.41M 0.16%
109,308
+54,708
+100% +$3.73M
2016 Q2
1 quarter
AOS icon
194
A.O. Smith
AOS
$8.52B
$7.4M 0.16%
149,886
+149,878
+1,873,475% +$7M
2015 Q4
3 quarters
ANSS icon
195
DELISTED
Ansys
ANSS
$7.34M 0.16%
79,300
– –
2016 Q2
1 quarter
DOX icon
196
Amdocs
DOX
$4.51B
$7.26M 0.15%
125,505
-61,900
-33% -$3.65M
2013 Q2
13 quarters
WEC icon
197
WEC Energy
WEC
$38.3B
$7.23M 0.15%
120,800
+1,900
+2% +$119K
2013 Q2
13 quarters
TRI icon
198
Thomson Reuters
TRI
$45.1B
$7.18M 0.15%
149,516
-213,086
-59% -$10.3M
2015 Q4
3 quarters
WLK icon
199
Westlake
WLK
$7.8B
$7.07M 0.15%
132,142
-106,745
-45% -$5.15M
2013 Q2
13 quarters
WST icon
200
West Pharmaceutical
WST
$28.9B
$7.01M 0.15%
+94,046
New +$7.47M
2016 Q3
0 quarters

Similar funds

First Quadrant's Q3 2016 Portfolio in Review

As of Q3 2016, First Quadrant held 963 positions worth $4.72B, up 4.2% from $4.53B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

First Quadrant's Q3 2016 filing shows 145 new, 195 increased, 238 reduced and 94 closed positions. Its largest new stake was Baxter International: 651,414 shares worth $31M. The largest sale was GE Aerospace, an estimated $40.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • First Quadrant's largest Q3 2016 buy was Baxter International: 651,414 shares worth $31M.
  • First Quadrant added most to PepsiCo in Q3 2016, an estimated $35.4M increase.
  • First Quadrant's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $40.3M.
  • First Quadrant fully exited ResMed in Q3 2016, selling an estimated $24.7M.
  • First Quadrant's ten largest holdings make up 13% of its $4.72B portfolio in Q3 2016.
  • First Quadrant opened 145 new positions and closed 94 in Q3 2016.
  • First Quadrant's portfolio value rose 4.2% quarter-over-quarter to $4.72B.

Based on First Quadrant's 13F filing for Q3 2016, filed 19 Oct 2016.